Nicotine: Medication or Scourge?

  • Murray E. Jarvik


The majority of people in most cultures uses psychoactive drugs. In our society only three such substances are legal and freely available: caffeine, alcohol, and nicotine. One of these, nicotine, is an endangered species as the laws against its use multiply in the United States. Almost everyone knows that smoking is hazardous to your health. It appears that nicotine is destined to become another illicit controlled substance. The disease-producing potential of smoking was first officially recognized by the Surgeon General1 and is now acknowledged to some extent even by smokers. In that first report, there are hints of the value of nicotine and I alluded to these in an early article.2 In this essay I want to point out some of the possible benefits of this drug.


Nicotine Withdrawal Radial Maze Chronic Nicotine Nicotine Administration Drug Abuse Research 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Smoking and Health: Report of the Advisory Committee to the Surgeon General of the Public Health Service. Washington, DC: US Department of Health, Education and Welfare, Public Health Service; 1964. DHEW Publication No. PHS 1103.Google Scholar
  2. 2.
    Jarvik ME. The role of nicotine in the smoking habit. In: Hunt WA, ed. Learning Mechanisms in Smoking. Chicago: Aldine; 1970:155–190.Google Scholar
  3. 3.
    Jarvik ME, Cullen JW, Gritz ER, Vogt TM, West LJ, eds. Research on Smoking Behavior. National Institute on Drug Abuse Research Monograph 17. Washington, DC: US Government Printing Office; December 1977.Google Scholar
  4. 4.
    US Department of Health and Human Services. US Surgeon General’s Report on the Health Consequences of Smoking. Nicotine Addiction. Washington, DC: US Government Printing Office; 1988.Google Scholar
  5. 5.
    Jaffe J. Tobacco smoking and nicotine dependence. In: Wonnacott S, Russell MAH, Stolerman IP, eds. Nicotine Psychopharmacology: Molecular, Cellular and Behavioural Aspects. Oxford: Oxford University Press; 1990.Google Scholar
  6. 6.
    Warburton DM. Is nicotine use an addiction? Bull Br Psychol Soc. 1989;4:166–170.Google Scholar
  7. 7.
    Goodman A, Rail TW, Nies AS, Taylor P, eds. Goodman and Gilman’s The Pharmacological Basis of Therapeutics. 7th ed. New York: Pergamon Press; 1990.Google Scholar
  8. 8.
    Stewart GG. A history of the medicinal use of tobacco 1492–1860. Med Hist. 1967;11:228–268.PubMedGoogle Scholar
  9. 9.
    Larson PS, Haag HB, Silvette H. Tobacco: Experimental and Clinical Studies. Baltimore, Md: Williams & Wilkins; 1961. Suppl 1,1968; Suppl 2, 1971;Suppl 3, 1975.Google Scholar
  10. 10.
    US Department of Health and Human Services. US Surgeon General’s Report on the Health Consequences of Smoking. Reducing the Health Consequences of Smoking: 25 Years of Progress. Washington, DC: US Government Printing Office; 1989.Google Scholar
  11. 11.
    Russell MAH. Nicotine intake and its control over smoking. In: S Wonnacott, MAH Russell, IP Stolerman, eds. Nicotine Psychopharmacology: Moleculary Cellular, and Behavioural Aspects. Oxford: Oxford University Press; 1990:374–418.Google Scholar
  12. 12.
    Wilbert J. Tobacco and Shamanism in South America. New Haven; Conn: Yale University Press, 1987.Google Scholar
  13. 13.
    Goldfarb TL, Gritz ER, Jarvik ME, Stolerman IP. Reactions to cigarettes as a function of nicotine and “tar.” Clin Pharmacol Ther. 1976;196:767–772.Google Scholar
  14. 14.
    Jones RT, Farrell TR, Herning RI. Tobacco smoking and nicotine tolerance. In: Krasnegor NA, ed. Self-Administration of Abused Substances: Methods for Study. NIDA Research Monograph 20. Washington, DC: US Department of Health, Education and Welfare; 1978.Google Scholar
  15. 15.
    Henningfield JE, Goldberg SR. Nicotine as a reinforcer in human subjects and laboratory animals. Pharmacol Biochem Behav. 1983;19: 989–992.PubMedCrossRefGoogle Scholar
  16. 16.
    West RJ. Nicotine: A dependence producing substance. In: Pomerleau, of Pomerleau, cs eds. Nicotine Replacement: A Critical Evaluation. New York: Alan R Liss; 1988:237–259.Google Scholar
  17. 17.
    Rose JE, Hickman CS. Citric acid aerosol as a potential smoking cessation aid. Chest. 1987.Google Scholar
  18. 18.
    Russell MA. Subjective and behavioural effects of nicotine in humans: Some sources of individual variation. Prog Brain Res. 1989;79:289–302.PubMedCrossRefGoogle Scholar
  19. 19.
    Beckett AH, Gorrod JW, Jenner P. The effect of smoking on nicotine metabolism in vivo in Man. J Pharma Pharmacol. 1971;23 (suppl):625–627.Google Scholar
  20. 20.
    Lewin L. Phantastica: Narcotic and Stimulating drugs—Their Use and Abuse. New York: EP Dutton; 1923.Google Scholar
  21. 21.
    Siegel RK. Intoxication: Life in Pursuit of Artificial Paradise. New York: EP Dutton, 1989.Google Scholar
  22. 22.
    Goldberg SR, Henningfield JE. Reinforcing effects of nicotine in humans and experimental animals responding under intermittent schedules of IV drug injection. Pharmacol Biochem Behav. 1988;30:227–234.PubMedCrossRefGoogle Scholar
  23. 23.
    Grenhoff J, Aston-Jones G, Svensson TH. Nicotinic effects on the firing pattern of midbrain dopamine neurons. Acta Physiol Scand. 1986;128:351–358.PubMedCrossRefGoogle Scholar
  24. 24.
    Imperato A, Mulas A, Di Chiara G. Nicotine preferentially stimulates dopamine release in the limbic system of freely moving rats. Eur J Pharmacol. 1986;132:337–338.PubMedCrossRefGoogle Scholar
  25. 25.
    Rowell PP, Carr LA, Garner AC. Stimulation of [3H] dopamine release by nicotine in rat nucleus accumbens. J Neurochem. 1987;49: 1449–1454.PubMedCrossRefGoogle Scholar
  26. 26.
    Blozovski D, Dumery V. Development of amygdaloid cholinergic mediation of passive avoidance learning in the rat. II. Nicotinic mechanisms. Exp Brain Res. 1987;67:70–76.PubMedCrossRefGoogle Scholar
  27. 27.
    Pert A, Clarke PBS. Nicotinic modulation of dopaminergic neurotransmission: functional implications. In: Martin WR, Van Loon GR, Iwamoto ET, Davis, L, eds. Tobacco Smoking and Nicotine: Advances in Behavioral Biology. New York: Plenum Press; 1987;31:169–189.Google Scholar
  28. 28.
    Reavill C, Stolerman IP. Locomotor activity in rats after intracerebral administration of nicotine. J Psychopharm. 1988. 2:99:273–278.Google Scholar
  29. 29.
    Grunberg NE, Bowen DJ, Morse DE. Effects of nicotine on body weight and food consumption in rats. Psychopharmacology (Berl). 1984;83:93–98.CrossRefGoogle Scholar
  30. 30.
    Rodin J, Salovey P. Health psychology. Ann Rev Psych. 1989;40:533–594.CrossRefGoogle Scholar
  31. 31.
    Winders SE, Grunberg NE. Effects of nicotine on body weight, food consumption and body composition in male rats. Life Sci. 1990; 46:1523–1530.PubMedCrossRefGoogle Scholar
  32. 32.
    Yoshida T, Yoshioka K, Hiraoka N, Kondo M. Effect of nicotine on norepinephrine turnover and thermogenesis in brown adipose tissue and metabolic rate in MSG obese mice. J Nutr Sci Vitaminol. 1990;36:123–130.PubMedCrossRefGoogle Scholar
  33. 33.
    Wellman PJ, Marmon MM, Reich S, Ruddle J. Effects of nicotine on body weight, food intake, and brown adipose tissue thermogenesis. Pharmacol Biochem Behav. 1986;246:1605–1609.CrossRefGoogle Scholar
  34. 34.
    Ashton H, Millman JE, Telford R, Thompson JW. The effect of caffeine, nitrazepam, and cigarette smoking on the contingent negative variation in man. Electroencephalogr Clin Neurophysiol. 1974;37:57–71.Google Scholar
  35. 35.
    Rose JE, Ananda S, Jarvik ME. Cigarette smoking during anxiety-provoking and monotonous tasks. Addict Behav. 1983;8:353–359.PubMedCrossRefGoogle Scholar
  36. 36.
    Gilbert DG, Welser R. Emotion, anxiety and smoking. In: Ney T, Gale A, eds. Smoking and Human Behavior. New York: John Wiley & Sons; 1989:171–196.Google Scholar
  37. 37.
    Pomerleau OF. Nicotine as a psychoactive drug: anxiety and pain reduction. Psychophar-macol Bull. 1986;22:863–883.Google Scholar
  38. 38.
    Ikard FF, Green DE, Horn D. A scale to differentiate between types of smoking as related to the management of affect. Int J Addict. 1969;4:649–659.Google Scholar
  39. 39.
    McKennell AC. Smoking motivation factors. Br J Soc Clin Psychol. 1970;9:8–22.PubMedCrossRefGoogle Scholar
  40. 40.
    Ikard FF, Tomkins S. The experience of affect as a determinant of smoking behavior: a series of validity studies. J Abnorm Psychol. 1973;81:172–181.PubMedCrossRefGoogle Scholar
  41. 41.
    Leventhal H, Avis N. Pleasure, addiction, and habit: factors in verbal report or factors in smoking behavior? J Abnorm Psychol. 1976; 85:478–488.PubMedCrossRefGoogle Scholar
  42. 42.
    Gorsuch RL, Butler MC. Initial drug abuse: a review of predisposing social psychological factors. Psychol Bull. 1976;63:120–137.CrossRefGoogle Scholar
  43. 43.
    Kandel D, Faust R. Sequence and stages in patterns of adolescent drug use. Arch Gen Psychol. 1975;32:923–932.Google Scholar
  44. 44.
    Botvin GJ, Wills T. Personal and social skills training: cognitive-behavioral approaches to substance abuse prevention. In: Bell CS, Battjes R, eds. Prevention Research: Deter-ring Drug Abuse Among Young Children and Adolescents. NIDA Research Monograph No. 63. Washington DC: US Government Printing Office; 1985:8–49.Google Scholar
  45. 45.
    Eysenck HJ. Personality and the maintenance of the smoking habit. In: Dunn WL, ed. Smoking Behaviour: Motives and Incentives. Washington, DC: Winston, 1973:113–146.Google Scholar
  46. 46.
    Kozlowski LT. Psychosocial influences on cigarette smoking. In: Smoking and Health: A Report of the Surgeon General. Washington, DC: US Department of Health, Education and Welfare; 1979. US DHEW publication PHS 79–50066.Google Scholar
  47. 47.
    Lerner JV, Vicary JR. Difficult temperament and drug use: analyses from the New York longitudinal study. J Drug Ed. 1984;14.1–7.CrossRefGoogle Scholar
  48. 48.
    Cherry N, Kiernan KE. Personality scores and smoking behaviour: a longitudinal study. Br J Prevent Soc Med. 1976;30:123–131.Google Scholar
  49. 49.
    Seltzer CC, Oechsli FW. Psychosocial characteristics of adolescent smokers before they started smoking: evidence of self-selection. J Chronic Dis. 1985;38:17–26.PubMedCrossRefGoogle Scholar
  50. 50.
    Nesbitt PD. Smoking, physiological arousal and emotional response. J Pers Soc Psychol. 1973;25:137–145.PubMedCrossRefGoogle Scholar
  51. 51.
    Schacter S. Nesbitt’s paradox. In: Dunn W, ed. Smoking Behaviour: Motives and Incentives. Washington, DC: Winston, 1973:147–156.Google Scholar
  52. 52.
    Shiftman S, Jarvik ME. Cigarette smoking, physiological arousal, and emotional response: Nesbitt’s paradox re-examined. Addict Behav. 1984;9:95–98.CrossRefGoogle Scholar
  53. 53.
    Schachter S. Pharmacological and psychological determinants of smoking. Ann Intern Med. 1978;88:104–14.PubMedGoogle Scholar
  54. 54.
    Epstein L, Collins F. The measurement of situational influences of smoking. Addict Behav. 1977;2:47–54.PubMedCrossRefGoogle Scholar
  55. 55.
    Schachter S, Kozlowski LT, Silverstein B. Effects of urinary pH on cigarette smoking. J Exp Psychol. 1977;106:13–19.Google Scholar
  56. 56.
    Epstein LH, Jennings JR. Smoking, stress, cardiovascular reactivity, and coronary heart disease. In: Matthews KA, Weiss SM, Detre T, et al, eds. Handbook of Stress, Reactivity and Car¬diovascular Disease. New York: John Wiley & Sons, 1986:268–292.Google Scholar
  57. 57.
    Schneider NG, Jarvik ME. Time course of withdrawal symptoms as a function of nicotine replacement. Psychopharmacology (Berl). 1984; 82:143–144.CrossRefGoogle Scholar
  58. 58.
    Jarvik ME, Hatsukami DK. Tobacco dependence. In: Ney T, Gale A, eds. Smoking and Human Behavior. Chichester, England: John Wiley & Sons; 1989:57–67.Google Scholar
  59. 59.
    Schachter S. Emotion, Obesity and Crime. New York: Academic Press; 1971.Google Scholar
  60. 60.
    Morley JE, Levine AS, Rowland NE. Stress induced eating. Life Sci. 1983;32:2169–2182.PubMedCrossRefGoogle Scholar
  61. 61.
    Shiftman S, Jarvik ME. Cigarette smoking, physiological arousal, and emotional response: Nesbitt’s paradox re-examined. Addict Behav. 1984;9:95–98.CrossRefGoogle Scholar
  62. 62.
    Stolerman IP, Bunker P, Jarvik ME. Nicotine tolerance in rats: Role of dose and dose interval. Psychopharmacology (Berl). 1974;34:317–324.CrossRefGoogle Scholar
  63. 63.
    Shiffman S. A cluster-analytic classification of smoking relapse episodes. Addict Behav. 1986;11:295–307.PubMedCrossRefGoogle Scholar
  64. 64.
    Warburton DM, Walters AC. Attentional processing. In: Ney T, Gale A, eds. Smoking and Human Behavior. New York: John Wiley & Sons; 1989.Google Scholar
  65. 65.
    Myrsten AL, Andersson K. Effects of cigarette smoking on human performance. In: Thornton RE, ed. Smoking Behaviour: Physiologiealand Psychological Influences. Edinburgh: Churchill Livingstone; 1978:156–167.Google Scholar
  66. 66.
    Snyder FR, Henningfield JE. Effects of nicotine administration following 12 hours of tobacco deprivation: assessment on computerized performance tasks. Psychopharmacology (Berl). 1989;97:17–22.CrossRefGoogle Scholar
  67. 67.
    Wesnes K, Warburton, DM. Effects of scopolamine and nicotine on human rapid information processing performance. Psychopharmacology (Berl). 1984;82:147–150.CrossRefGoogle Scholar
  68. 68.
    Wesnes K, Warburton DM. The effects of cigarette smoking and nicotine tablets upon human attention. In: Thornton RE, ed. Smoking Behaviour: Physiological and Psychological Influences. New York: Churchill Livingstone; 1978:131–147.Google Scholar
  69. 69.
    Cotten DJ, Thomas JR, Stewart D. Immediate effects of cigarette smoking on simple reaction time of college male smokers. Percept Mot Skills. 1971;33:336.PubMedCrossRefGoogle Scholar
  70. 70.
    Morgan SF, Pickens RW. Reaction time performance as a function of cigarette smoking procedure. Psychopharmacology (Berl). 1982; 77(4):383–386.CrossRefGoogle Scholar
  71. 71.
    Tong JE, Leigh G, Campbell J, Smith D. Tobacco smoking, personality and sex factors in auditory vigilance performance. Br J Psychol. 1977;68:365–370.PubMedCrossRefGoogle Scholar
  72. 72.
    Snyder FR, Nemeth-Coslett R, Shanet LP, Henningfield JE. Cognitive, subjective and physiological effects of nicotine in nonsmokers. Pharmacol Biochem Behav. 27:592; 1987.CrossRefGoogle Scholar
  73. 73.
    Snyder FR, Henningfield JE. Effects of nicotine administration following 12 h of tobacco deprivation: assessment on computerized performance tasks. Psychopharmacology (Berl). 1989;97:17–22.CrossRefGoogle Scholar
  74. 74.
    Heishman SJ, Snyder FR, Henningfield JE. Effect of repeated nicotine administration in non-smokers. In: Harris LS, ed. Problems of Drug Dependence. NIDA Research Monograph. 1991;105:314–315.Google Scholar
  75. 75.
    Snyder FR, Jewel JD. Nicotine administration in non-smokers. In Harris LS, ed. Problems of Drug Dependence. Nida Research Monograph. In press.Google Scholar
  76. 76.
    Henningfield JE. Dose-related actions of nicotine on behavior and physiology: review and implications for replacement therapy for nicotine dependence. J Subst Abuse. 1989;1:301–317.Google Scholar
  77. 77.
    Hindmarch I, Kerr JS, Sherwood N. Effects of nicotine gum on psychomotor performance in smokers and non-smokers. Psychopharmacology (Berl). 1990;100(4):535–541.CrossRefGoogle Scholar
  78. 78.
    Weiss B, Laties VG. Enhancement of human performance by caffeine and the amphetamines. Pharmacol Rev. 1962;14:1–36.PubMedGoogle Scholar
  79. 79.
    Aigner TG, Mitchell SJ, Aggleton JP, et al. Effects of scopolamine and physostigmine on recognition memory in monkeys with ibotenicacid lesions of the nucleus basalis of Meynert. Psychopharmacology (Berl). 1987;92(3):292–300.CrossRefGoogle Scholar
  80. 80.
    Sternberg DE, Jarvik ME. Memory functions in depression. Arch Gen Psychiatry. 1976; 33:219–224.PubMedGoogle Scholar
  81. 81.
    Houston JP, Schneider NG, Jarvik ME. Effects of smoking on free recall and organization. Am J Psychiatry. 1978;135:220–222.PubMedGoogle Scholar
  82. 82.
    Frankenhaeuser M, Myrsten AL, Post B, Johansson G. Behavioral and physiological effects of cigarette smoking in a monotonous situation. Psychopharmacology (Berl). 1971; 22:1–7.CrossRefGoogle Scholar
  83. 83.
    Williams DG. Effects of cigarette smoking on immediate memory and performance in different kinds of smoker. Br J Psychol. 1980;71: 83–90.PubMedCrossRefGoogle Scholar
  84. 84.
    West RJ, Jarvis M J. Effects of nicotine on finger tapping rate in non-smokers. Pharmacol Biochem Behav. 1986;25(4):727–731.PubMedCrossRefGoogle Scholar
  85. 85.
    Palmen E. Ueber die einwirkung des tabkrauchesn auf die doerperliche leistungsf aehigkeit. Skaninavisches Archiv fuer Physiologic 1911;24:187–196.Google Scholar
  86. 86.
    Johnson OJ. Effects of smoking on mental and motor efficiency. Psychol Clin. 1918;12:132–140,230–235.Google Scholar
  87. 87.
    Hull CL. The influence of tobacco smoking on mental and motor efficiency. Psychol Monogr. 1924;33(150):7–16.Google Scholar
  88. 88.
    Elrod K, Buccafusco JJ, Jackson WJ. Nicotine enhances delayed matching-to-sample performance by primates. Life Sci. 1988;43(3): 277–287.PubMedCrossRefGoogle Scholar
  89. 89.
    Clarke PBS, Fu DS, Jakubovic A, Fibiger HC. Evidence that mesolimbic dopaminergic activation underlies the locomotor stimulant action of nicotine in rats. J Pharmacol Exp Ther. 1988;246:701–708.PubMedGoogle Scholar
  90. 90.
    Levin ED, Castonguay M, Ellison GD. Effects of the nicotinic receptor blocker mecamylamine on radial-arm maze performance in rats. Behav Neural Biol. 1987;48(2):206–212.PubMedCrossRefGoogle Scholar
  91. 91.
    Levin ED, Ellison GD, Salem C, Jarvik M, Gritz E. Behavioral effects of acute hexamethonium in rats chronically intoxicated with nicotine. Physiol Behav. 1988;44:355–359.PubMedCrossRefGoogle Scholar
  92. 92.
    Mundy WR, Iwamoto ET. Actions of nicotine on the acquisition of an autoshaped lever-touch response in rats. Psychopharmacology (Berl). 1988;94:267–274.CrossRefGoogle Scholar
  93. 93.
    Levin ED, Lee C, Rose JE, et al. Chronic nicotine and withdrawal effects on radial-arm maze performance in rats. Behav Neural Biol. 1990;53:269–76.PubMedCrossRefGoogle Scholar
  94. 94.
    Reavill C. Action of nicotine on dopamine pathways and implications for Parkinson’s disease. In: Wonnacott S, Russell M AH, Stolerman IP, eds. Nicotine Psychopharmacology: Molecular, Cellular and Behavioural Aspects. Oxford: Oxford University Press, 1990:307–310.Google Scholar
  95. 95.
    Moll H. The treatment of post encephalitic parkinsonism by nicotine. Br Med J. 1926;1:1079–1081.PubMedCrossRefGoogle Scholar
  96. 96.
    Kahn HA. The Dorn study of smoking and mortality among US veterans: report on eight and one half years of observation. In: Haenzel W, ed. Epidemiological Approaches to the Study of Chronic Diseases. National Cancer Institute Monograph. Bethesda, Md: US Department of Health, Education and Welfare; 1966.Google Scholar
  97. 97.
    Kessler II, Diamond EL. Epidemiologic studies of Parkinson’s disease. Smoking and Parkinson’s disease: a survey and explanatory hypothesis. Am J Epidemiol. 1971;94:16–25.PubMedGoogle Scholar
  98. 98.
    Janson AM, Fuxe K, Sundstrom E, Agnati LF, Goldstein M. Chronic nicotine treatment partly protects against the l-methyl-4-phenyl-l,2,3,6-tetrahydropyridine-induced degeneration of nigrostriatal dopamine neurons in the black mouse. Acta Physiol Scand. 1988;132:589–591.PubMedCrossRefGoogle Scholar
  99. 99.
    Devor EJ, Isenberg KE. Nicotine and Tourette’s syndrome. Lancet. 1989;2:1046.PubMedCrossRefGoogle Scholar
  100. 100.
    Sanberg PR, McConville BJ, Fogelson HM, et al. Nicotine potentiates the effects of haloperidol in animals and in patients with Tourette syndrome. Biomed Pharmacother. 198;43(1):19–23.Google Scholar
  101. 101.
    Lashner BA, Hanauer SB, Silverstein MD. Testing nicotine gum for ulcerative colitis patients: experience with single-patient trials. Dig Dis Sci. 1990;35:827–832.PubMedCrossRefGoogle Scholar
  102. 102.
    Srivastava ED, Hallett MB, Rhodes J. Effect of nicotine and cotinine on the production of oxygen free radicals by neutrophils in smokers and non-smokers. Hum Toxicol. 1989;8(6): 461–463.PubMedCrossRefGoogle Scholar
  103. 103.
    Hickey RJ. Nicotine and ulcerative colitis. Gut. 1989;30(3):416–418.PubMedCrossRefGoogle Scholar
  104. 104.
    Sahakian B, Jones G, Levy R, Gray J, Warburton D. The effects of nicotine on attention, information processing, and short-term memory in patients with dementia of the Alzheimer type. Br J Psychiatry. 1989;154:797–800.PubMedCrossRefGoogle Scholar
  105. 105.
    Newhouse PA, Sunderland T, Tariot PN, et al. Intravenous nicotine in Alzheimer’s disease: a pilot study. Psychopharmacology (Berl). 1988; 95(2):171–175.CrossRefGoogle Scholar
  106. 106.
    Barclay L, Kheyfets S. Tobacco use in Alzheimer’s disease. Prog Clin Biol Res. 1989;317:189–194.PubMedGoogle Scholar
  107. 107.
    Gothe B, Strohl KP, Levin S, Cherniack NS. Nicotine: a different approach to treatment of obstructive sleep apnea. Chest. 1985;87:11–17.PubMedCrossRefGoogle Scholar
  108. 108.
    Hughes JR, Higgins ST, Hatsukami D. Effects of abstinence from tobacco: a critical review. In: Kozlowski LT, Annis HM, Cappell HD, et al. Research Advances in Alcohol and Drug Problems. New York: Plenum Publishing; 1990:317–398.Google Scholar
  109. 109.
    Spitzer RL, Williams JW. Structured Clinical Interview for DSM-III (SCID). New York: Biometrics Research Department, New York State Psychiatric Institute; 1987.Google Scholar
  110. 110.
    Goodwin FK, Jamison KR. Manic-Depressive Illness. New York: Oxford University Press; 1990.Google Scholar
  111. 111.
    Jamison KR. Mood disorders and patterns of creativity in British writers and artists. Psychiatry. 1989;52(2): 125–134.PubMedGoogle Scholar
  112. 112.
    Reuter P, MacCoun R, Murphy P. Money From Crime: A Study of the Economics of Drug Dealing in Washington, DC. Santa Monica: Rand Corporation; June 1990.Google Scholar
  113. 113.
    Benowitz NL. Pharmacologic aspects of cigarette smoking and nicotine addiction. N Engl J Med. 1988;319(20): 1318–1330.PubMedCrossRefGoogle Scholar
  114. 114.
    Rose JE, Behm F. Refined cigarette smoke as a method for reducing nicotine intake. Pharmacol Biochem Behav. 1987;28:305–310.PubMedCrossRefGoogle Scholar
  115. 115.
    Goldfarb TL, Jarvik ME, Glick SD. Cigarette nicotine content as a determinant of human smoking behavior. Psychopharmacology (Berl). 1970;17:89–93.CrossRefGoogle Scholar

Copyright information

© Springer-Verlag New York, Inc. 1992

Authors and Affiliations

  • Murray E. Jarvik

There are no affiliations available

Personalised recommendations